Related Experiment Video
Updated: Jul 17, 2026
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
[Immunotherapy and malignant mesothelioma: clinical perspectives]
Marc Grégoire1, Frédéric Ebstein
1Inserm, Unité 601, Institut de Biologie, 9 quai Moncousu, 44093 Nantes Cedex. marc.gregoire@nantes.inserm.fr
Bulletin Du Cancer
|January 24, 2007
Summary
Malignant pleural mesothelioma (MPM) shows potential for immune system response. Immunotherapy and chemo-immunotherapy offer promising, though challenging, new treatment strategies for this rare cancer.
Area of Science:
- Oncology
- Immunology
Context:
- Malignant pleural mesothelioma (MPM) is a rare cancer with a poor prognosis and limited treatment options.
- Current treatments like chemotherapy, radiotherapy, and surgery have shown restricted efficacy against MPM.
Purpose:
- To review the role of immunotherapy in treating malignant pleural mesothelioma.
- To explore past and recent developments in immunotherapy strategies for MPM.
Summary:
- Some MPM cases show spontaneous tumor regression or response to immunotherapy, indicating potential immune system engagement.
- Animal studies and clinical trials suggest immunotherapy and chemo-immunotherapy are effective for early-stage MPM.
- Advances in early detection may improve treatment efficiency and patient monitoring for MPM.
Impact:
- Immunotherapy presents a promising, albeit challenging, approach for treating MPM.
- This review highlights the evolving landscape of cancer immunotherapy for MPM.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...